We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CRISPR Screening Reveals Drug Target for Sickle Cell Disease

News   Jul 19, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
CRISPR Screening Reveals Drug Target for Sickle Cell Disease

Laura Mason

Science Writer

 
 
 

RELATED ARTICLES

Microfluidically-linked BBB and Brain-chips Opens Another Dimension for Neurological Research

News

Linked BBB and brain-chips strike the perfect balance of complexity and simplicity for studying the neurovascular unit.

READ MORE

Identical Mutation, Different Symptoms: Researchers Outline 'Modified Penetrance' Hypothesis

News

Researchers have uncovered a molecular mechanism behind one of biology's long-standing mysteries: why individuals carrying identical gene mutations for a disease end up having varying severity or symptoms of the disease. I

READ MORE

Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Drugs

News

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE